Mergers & Acquisitions (M&A)

Perrigo Acquires Scar Management Brand

Ajinomoto Sells French Sweetener Assets for €1

Alvogen to buy Pfizer Drugs for US Market

Monsanto Drops Bid for Syngenta

Pfizer Gets Green Light for Hospira Acquisition

PPG Agrees to Buy Remaining Stake in ChemFil Canada Joint Venture

Valeant to Acquire Sprout and Enter Sexual Health Market

Tosaf Completes Acquisition of Adtec Colorant in the US

Roche Agrees to Buy Kapa Biosystems to Boost Next-generation Portfolio

Syngenta Plans to Sell Flowers Seeds Business

LyondellBasell Sells Argentina PP Subsidiary

Ecolab to Acquire Select Assets of Swisher Hygiene

Mallinckrodt to Buy Immunotherapy Firm Therakos

Germany’s Merck Wins Last Antitrust Nod for Sigma-Aldrich

Chiltern to Acquire Theorem Clinical Research

K+S Private Shareholders Oppose Potash Bid

LyondellBasell to Acquire SJS Plastiblends

K+S Again Rejects – Unchanged – Potash Bid

EU Approves Pfizer-Hospira Deal With Strings

ChemicalInvest Launched by DSM and CVC

Shire Makes Offer for Baxalta

Rumors of BASF Bid for Syngenta Resurface

M&A Carousel Turns Faster as Deals Set New Records

Teva to Acquire the Generics Activities of Allergan for Over $40 Billion

Johnson Matthey to divest Alfa Aesar Research Chemicals business to Thermo Fisher for £256 million

HCS to Acquire Shu-Chem of Texas

Ardian Acquires ES and IM from DPx Holdings

EU Approves Sale of Kem One to OpenGate

Celgene Offers $7.2 Billion for Receptos

German Antitrust Authority Allows BASF-Siegfried Deal

Platform Offers $2.3 Billion for Alent

DKSH Acquires Andreas Jennow

AstraZeneca Sells Gastro Treatment to Swiss Group Tillotts

Axalta Coatings Acquires its Distributor

Clariant Closes Companhia Brasileira de Bentonita Buy

888 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Universität Hohenheim - Institut für Lebensmitteltechnik

Clariant International Ltd

Kolb Distribution Ltd.

Novartis International AG

GlaxoSmithKline (GSK) plc

Emerson Automation Solutions

Azelis Corporate Services NV

Honeywell GmbH

IMCD Group B.V.

Simon-Kucher & Partners Strategy & Marketing Consultants GmbH

Immedica Pharma AB

Sanofi S.A.

Pfizer, Inc.

Proventis Partners

Frost & Sullivan

Colonial Chemical Soutions

Americo Chemical Products

The Valence Group

AbbVie Inc.

Eastman Chemical Company

DSM Pharmaceutical Products

Caldic Deutschland Chemie B. V.

Sumitomo Chemical

Asahi Kasei Europe

Trinseo LLC

Dow Chemical Company

Evonik Industries AG

CABB Group GmbH

Biogen Inc.

OneSource Specialty Pharma Limited

Perstorp Holding AB

Camelot Management Consultants AG

De Paauw Sustainable Resources (DPSR)

A.T. Kearney GmbH

Nova Chemicals

Kensing, LLC.